Study identifies patients with obesity most likely to benefit from GLP-1-based treatment
July 16, 2026
July 16, 2026
ROCHESTER, Minnesota, July 16 [Category: BizHospital] -- The Mayo Clinic issued the following news release:
* * *
Study identifies patients with obesity most likely to benefit from GLP-1-based treatment
*
Research identifies subtype of `hungry gut' obesity phenotype
ROCHESTER, Minn. -Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a poten . . .
* * *
Study identifies patients with obesity most likely to benefit from GLP-1-based treatment
*
Research identifies subtype of `hungry gut' obesity phenotype
ROCHESTER, Minn. -Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a poten . . .